GLP-1 Market
LLY $1274.22 ▼ -2.5% NVO $39.03 ▼ -1.0% PFE $30.01 ▼ -1.3% VKTX $24.40 ▼ -5.5% KLRA $12.85 ▼ -3.2% GPCR $21.19 ▼ -3.4% RHHBY $61.17 ▲ +2.6%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Metfomin

Company
Sherihan AboElyazed Mohamed Khalil
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
3 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

3 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 24, 2026

Find a Clinical Trial Near Me

See recruiting studies for Metfomin and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT07065591

    Anti-Diabetic Drug, Exercise and Healthy Diet for Knee Osteoarthritis With Overweight/Obesity

    Not yet reported The University of Hong Kong 100 participants Est. completion 2028-07-17 1 site
    Osteoarthritis
    View official trial listing →
  • Recruiting NCT NCT07395960

    The Efficacy and Safety of Metformin Intervention in Elderly Overweight or Obesity With Mild Cognitive Impairment

    Not yet reported, Not yet reported Fudan University 54 participants Est. completion 2026-09-30 1 site Stand-alone
    Other conditions: Mild Cognitive Impairment, Overweight or Obesity, Elderly
    View official trial listing →
  • Recruiting NCT NCT07630779

    Efficacy of Alpha Lipoic Acid Combined With Myo-Inositol in Non-Diabetic PCOS Patients

    Not yet reported Beni-Suef University 180 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Poly Cystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT00232583

    Preservation of Beta-cell Function in Type 2 Diabetes Mellitus

    Not yet reported University of Texas Southwestern Medical Center 58 participants Est. completion 2011-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01021579

    Effects of Metformin Plus Simvastatin on Polycystic Ovarian Syndrome (PCOS): A Prospective, Randomized, Double-Blind, Placebo-Controlled Study

    Not yet reported Fasa University of Medical Sciences 84 participants Est. completion 2009-11 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT01474967

    Effect of Dosage of Metformin on Menstruation and Lipid Profile in Women With Polycystic Ovary Syndrome

    Not yet reported Hormozgan University of Medical Sciences 50 participants Est. completion 2011-02 1 site Stand-alone
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Status unknown NCT NCT01930864

    Metformin Plus Irinotecan for Refractory Colorectal Cancer

    Not yet reported Barretos Cancer Hospital 41 participants Est. completion 2020-12-01 2 sites Stand-alone
    Other conditions: Colorectal Neoplasms, Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT02188186

    Therapeutic Efficacy of Triple Combination in Drug-naïve Korean Type 2 Diabetic Patients

    Not yet reported Seoul National University Bundang Hospital 200 participants Est. completion 2018-09 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT02730741

    Study of the Efficacy and Tolerance of Oral Treatment With a Total Freeze-dried Culture of Lcr Restituo® Sachets (Lactobacillus Rhamnosus Lcr35®) on Intolerance to Metformin (Diarrhoea) in Patients With Diabetes Type 2

    Not yet reported Biose 60 participants 1 site
    Other conditions: Antidiarrhoea
    View official trial listing →
  • Completed NCT NCT02778776

    Combination of Metformine/Inulin Versus Metformin on Prostate Benign Hyperplasia in Metabolic Syndrome

    Not yet reported Centro Universitario de Ciencias de la Salud, Mexico 40 participants Est. completion 2015-06 1 site Stand-alone
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT02981329

    Fetal Hemoglobin Induction Treatment Metformin

    Not yet reported Baylor College of Medicine 37 participants Est. completion 2020-07-20 2 sites Stand-alone
    Other conditions: Sickle Cell Anemia, Sickle Cell Disease, Hemoglobin Disorder
    View official trial listing →
  • Status unknown NCT NCT04485845

    Metformin Versus Vildagliptin in Reducing Risk of Metabolic Syndrome Complications Progression

    Not yet reported Cairo University 39 participants Est. completion 2020-09-30 1 site
    Metabolic syndrome Other conditions: Diabete Type 2, Kidney Insufficiency
    View official trial listing →
  • Completed NCT NCT06836128

    The Combined Effect of N-Acetyl Cysteine and Metformin in Polycystic Ovary Syndrome Patients

    Not yet reported Cairo University 102 participants Est. completion 2026-03-30 1 site Stand-alone
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT07120828

    The Role of CYP8B1 Polymorphisms in Modulating the Biochemical Pathways Affected by SGLT2 Inhibitors in T2DM and Obesity

    Not yet reported Erbil Polytechnic University 260 participants Est. completion 2026-03-15 1 site
    Type 2 diabetes Other conditions: Obese Diabetics, Obese Patients (BMI ≥ 30 kg/m²)
    View official trial listing →
  • Completed NCT NCT07145827

    Effect of Metformin on Endometrial Thickness in Postmenopausal Breast Cancer Patients Receiving Tamoxifen

    Not yet reported Uruk University 60 participants Est. completion 2025-07-01 1 site Stand-alone
    Other conditions: Breast Cancer, Endometrial Hyperplasia and Endometrial Cancers
    View official trial listing →
  • Not yet recruiting NCT NCT07495748

    Comparative Evaluation of Topical Metformin and Topical Tranexamic Acid in Melasma

    Not yet reported Foundation University Islamabad 70 participants Est. completion 2027-07-01 1 site Stand-alone
    Other conditions: Melasma
    View official trial listing →
  • Not yet recruiting NCT NCT07622290

    Metformin Treatment for Children With Obesity-associated Asthma

    Not yet reported Prof Ibrahim Janahi 182 participants Est. completion 2028-03 1 site
    Other conditions: Obesity-associated Asthma
    View official trial listing →
  • Completed NCT NCT07738692

    Effects of Various Types of Ultrasound Therapy in Knee Osteoarthritis

    Not yet reported Horus University 80 participants Est. completion 2026-06-30 1 site Stand-alone
    Osteoarthritis
    View official trial listing →
  • Not yet recruiting NCT NCT07891234

    Effect of SGLT2 Inhibitor on Metabolic-Dysfunction-Associated Fatty Liver Disease in Patients With Insulin Resistance

    Not yet reported Sherihan AboElyazed Mohamed Khalil 66 participants Est. completion 2027-10-01 1 site
    Prediabetes
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Metfomin, Metfomin 500 mg, PreDM/Met

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.